4,242 Shares in Agilent Technologies, Inc. (NYSE:A) Bought by Mufg Securities Americas Inc.

Mufg Securities Americas Inc. bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 4,242 shares of the medical research company's stock, valued at approximately $570,000.

Several other hedge funds also recently bought and sold shares of the stock. CKW Financial Group lifted its stake in shares of Agilent Technologies by 114.9% during the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after purchasing an additional 100 shares during the period. Global X Japan Co. Ltd. grew its position in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after acquiring an additional 116 shares in the last quarter. Redwood Park Advisors LLC acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $27,000. Lee Danner & Bass Inc. purchased a new stake in shares of Agilent Technologies during the fourth quarter valued at approximately $29,000. Finally, Hanson & Doremus Investment Management lifted its position in shares of Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after purchasing an additional 105 shares in the last quarter.

Insider Activity

In other news, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares in the company, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company's stock, valued at approximately $2,657,456.28. This trade represents a 8.05% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Agilent Technologies Stock Down 2.1%

NYSE A traded down $2.39 on Wednesday, reaching $111.10. The company had a trading volume of 747,415 shares, compared to its average volume of 1,905,728. The company's fifty day moving average is $110.23 and its 200-day moving average is $127.89. The firm has a market capitalization of $31.67 billion, a price-to-earnings ratio of 25.56, a price-to-earnings-growth ratio of 3.20 and a beta of 1.27. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $154.65.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms recently issued reports on A. Wells Fargo & Company dropped their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Jefferies Financial Group lowered their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Robert W. Baird reduced their target price on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research note on Thursday, February 27th. Barclays decreased their target price on shares of Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Finally, TD Cowen lifted their price target on Agilent Technologies to $135.00 and gave the company a "buy" rating in a report on Thursday, April 10th. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and an average target price of $143.00.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.